Sidley represented Mediwelcome Healthcare Management & Technology Inc. (HKEX:2159) (Mediwelcome) as Hong Kong legal counsel in its initial public offering (IPO) on the Main Board of the Stock Exchange of Hong Kong (HKEX). The listing is completed at a market capitalization of HK$600 million (equivalent to approximately US$77.39 million). CEB International Capital Corporation Limited acted as the sole sponsor and sole global coordinator in the transaction.
Mediwelcome is the largest provider in the integrated healthcare marketing solutions market for cardio-cerebral-vascular diseases in China in terms of revenue in 2019, according to the CIC Report. Among the global top ten pharmaceutical companies in terms of revenue in 2019, five were Mediwelcome’s customers during the track record period.
The Sidley team on this IPO was led by partner Raymond Oh. Other team members included senior associate Ariel Lin; China advisor Chris Wang; senior legal assistant Zoe Yang; and legal assistants Kaiwen Xu and Ru Jia.
Sidley is a multidisciplinary one-stop service shop in the market for life sciences clients. We advise clients across different stages of their life cycles, ranging from formation, corporate governance, and compliance operations in the startup period, to collaboration, licensing, commercialization, and filing in the business development phase, to initial public offering, refinancing, and bonds/notes issues in the raising capital stage, to domestic and overseas mergers and acquisitions, asset restructuring, equity incentive plans, and privatization transactions when clients expand their businesses.
